claim: targeted immunosuppression distinguishes covid-19 from influenza in moderate and severe disease
evidence_1: single cell transcriptional profiling of covid-19 and influenza subjects with respiratory failure identified profound suppression in type i and type ii interferon signaling in covid-19 patients across multiple clusters.